NASDAQ
Arrowhead Pharmaceuticals, Inc. (ARWR) has a current ratio of 4.86x as of Monday, May 25, 2026. This represents a 19.61% increase compared to its 12-month average of 4.07x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.